Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 11/20 | 0.41 |
| ▸ | CNR2 | P34972 | 9/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.39 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | GPR6 | P46095 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.37 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.37 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30700983 | 0.76 | CNR2 (0.65) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL29874629 | 0.76 | CNR2 (0.65) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL14370552 | 0.74 | CNR1 (0.74) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL14578511 | 0.74 | CNR1 (0.74) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL24805148 | 0.74 | CNR1 (0.74) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL23373955 | 0.74 | CNR1 (0.74) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL12160438 | 0.74 | CNR1 (0.74) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL14574408 | 0.74 | CNR1 (0.74) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL23883085 | 0.71 | PTGS2 (0.43) | CNR1CNR2OPRM1GPR55TRPA1 | |
| SCHEMBL30435622 | 0.71 | PTGS2 (0.43) | CNR1CNR2OPRM1GPR55TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552733-B2 | Terpenophenolic compounds and their use | PHYTOTHERAPEUTIX LIMITED (GB) | 2026-02-17 | — | — | US | disclosed |
| US-20230227390-A1 | TERPENOPHENOLIC COMPOUNDS AND THEIR USE | PHYTOTHERAPEUTIX LIMITED (GB) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227390-A1 | TERPENOPHENOLIC COMPOUNDS AND THEIR USE | TPMT, MALT1, UGT1A1 | CNR1 7/4885CNR2 15/4885OPRM1 223/4885 |
| US-12552733-B2 | Terpenophenolic compounds and their use | TPMT, MALT1, CNR1 | CNR1 3/4885CNR2 4/4885OPRM1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.